Yanqiong Shen
Hefei, 230601, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Multivalent mRNA vaccine platform with compatible antigens conferred broad-spectrum protection against orthoebolaviruses' exposure.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 18, 2026
A single-chain mRNA vaccine co-expressing GPC and NP provides complete protection against lethal Dabie bandavirus challenge in mice.
Journal: Molecular therapy. Nucleic acids
Published: July 21, 2025
cGAS mRNA-Based Immune Agonist Promotes Vaccine Responses and Antitumor Immunity.
Journal: Cancer immunology research
Published: August 19, 2024
An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge.
Journal: Antiviral research
Published: June 01, 2024
Boosting with Omicron-specific mRNA vaccine or historical SARS-CoV-2 vaccines elicits discriminating immune responses against Omicron variants.
Journal: Acta pharmaceutica Sinica. B
Published: May 22, 2024
Generation of tolerogenic antigen-presenting cells in vivo via the delivery of mRNA encoding PDL1 within lipid nanoparticles.
Journal: Nature biomedical engineering
Published: January 08, 2024
Heterogeneous-Structure-Based AuNBs@TiO2 Nano-Photosensitizers for Computed Tomography Imaging Guided NIR-II Photodynamic Therapy and Cancer Metastatic Prevention.
Journal: Advanced healthcare materials
Published: November 28, 2023
A potential bivalent mRNA vaccine candidate protects against both RSV and SARS-CoV-2 infections.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 31, 2023
Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours.
Journal: Nature nanotechnology
Published: July 29, 2022
Last Updated: 09/26/2026